MA42246A - Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv - Google Patents

Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv

Info

Publication number
MA42246A
MA42246A MA042246A MA42246A MA42246A MA 42246 A MA42246 A MA 42246A MA 042246 A MA042246 A MA 042246A MA 42246 A MA42246 A MA 42246A MA 42246 A MA42246 A MA 42246A
Authority
MA
Morocco
Prior art keywords
variable domain
single variable
domain antibodies
immunoglobulin single
fusion immunoglobulin
Prior art date
Application number
MA042246A
Other languages
English (en)
Inventor
Morgan Gilman
Barney Graham
Jason Mclellan
Iebe Rossey
Xavier Saelens
Bert Schepens
Original Assignee
Us Health
Dartmouth College
Univ Gent
Vib Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57545045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA42246(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP15178653.0A external-priority patent/EP3124042A1/fr
Application filed by Us Health, Dartmouth College, Univ Gent, Vib Vzw filed Critical Us Health
Publication of MA42246A publication Critical patent/MA42246A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA042246A 2015-06-18 2016-06-20 Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv MA42246A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562181522P 2015-06-18 2015-06-18
EP15178653.0A EP3124042A1 (fr) 2015-07-28 2015-07-28 Anticorps à domaine variable unique contre la protéine f prefusion du virus respiratoire syncytial (rsv)
EP15191868 2015-10-28

Publications (1)

Publication Number Publication Date
MA42246A true MA42246A (fr) 2018-05-02

Family

ID=57545045

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042246A MA42246A (fr) 2015-06-18 2016-06-20 Anticorps à domaine variable unique d'immunoglobuline contre la protéine f de pré-fusion de rsv

Country Status (18)

Country Link
US (2) US10501528B2 (fr)
EP (1) EP3313432A1 (fr)
JP (1) JP6836760B2 (fr)
KR (1) KR20180056631A (fr)
CN (1) CN108472343B (fr)
AU (1) AU2016277887B2 (fr)
BR (1) BR112017027303A2 (fr)
CA (1) CA2989378A1 (fr)
CL (1) CL2017003260A1 (fr)
HK (1) HK1254779A1 (fr)
IL (1) IL256315B2 (fr)
MA (1) MA42246A (fr)
MX (1) MX394666B (fr)
MY (1) MY192870A (fr)
PH (1) PH12017502356A1 (fr)
RU (1) RU2730671C2 (fr)
UA (1) UA123584C2 (fr)
WO (1) WO2016203052A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2730671C2 (ru) * 2015-06-18 2020-08-24 Виб Взв Иммуноглобулин с одним вариабельным доменом против f-белка pcb
WO2019024979A1 (fr) * 2017-07-31 2019-02-07 Institute For Research In Biomedicine Anticorps à domaines fonctionnels dans la région de coude
US20200129446A1 (en) 2018-10-29 2020-04-30 University Of Iowa Research Foundation Respiratory syncytial virus (rsv) polyanhydride nanoparticle vaccine
CN111808187B (zh) * 2019-08-02 2022-05-17 苏州高泓利康生物科技有限公司 针对呼吸道合胞病毒的蛋白结合分子
CN116063468A (zh) 2022-08-30 2023-05-05 武汉班科生物技术有限公司 中和呼吸道合胞病毒的c-型单域抗体及应用
WO2025149667A1 (fr) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Conjugués anticorps-médicament et leurs utilisations
WO2025228370A1 (fr) * 2024-04-29 2025-11-06 星济生物(苏州)有限公司 Protéine de liaison à l'antigène neutralisant le virus respiratoire syncytial et son utilisation
CN120248057B (zh) * 2024-12-26 2025-12-02 北京华诺泰生物医药科技有限公司 一种呼吸道合胞病毒f蛋白突变体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997830A1 (fr) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. Molécules à liaison spécifiques RSV et leur moyen de fabrication
US8563002B2 (en) * 2007-12-24 2013-10-22 Glaxosmithkline Biologicals, S.A. Recombinant RSV antigens
LT2285408T (lt) 2008-06-05 2019-01-25 Ablynx N.V. Aminorūgščių sekos, nukreiptos prieš viruso apvalkalo baltymus, ir tokias sekas turintys polipeptidai, skirti virusinių ligų gydymui
CN102459332B (zh) * 2009-06-05 2015-08-19 埃博灵克斯股份有限公司 用于预防和/或治疗呼吸道感染的单价、二价和三价抗人呼吸道合胞病毒(hrsv)纳米抗体构建体
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
WO2011064382A1 (fr) * 2009-11-30 2011-06-03 Ablynx N.V. Séquences d'acides aminés améliorées dirigées contre le virus syncytial respiratoire humain (hrsv) et polypeptides comprenant celles-ci pour la prévention et/ou le traitement d'infections du tractus respiratoire
RU2730671C2 (ru) * 2015-06-18 2020-08-24 Виб Взв Иммуноглобулин с одним вариабельным доменом против f-белка pcb

Also Published As

Publication number Publication date
PH12017502356B1 (en) 2018-06-25
BR112017027303A2 (en) 2018-09-04
PH12017502356A1 (en) 2018-06-25
US20180179266A1 (en) 2018-06-28
AU2016277887A1 (en) 2018-01-18
MX2017016590A (es) 2018-11-09
RU2018101662A3 (fr) 2019-11-06
IL256315A (en) 2018-02-28
WO2016203052A1 (fr) 2016-12-22
RU2018101662A (ru) 2019-07-22
US10501528B2 (en) 2019-12-10
MY192870A (en) 2022-09-13
MX394666B (es) 2025-03-21
RU2730671C2 (ru) 2020-08-24
CN108472343A (zh) 2018-08-31
CL2017003260A1 (es) 2018-05-11
JP6836760B2 (ja) 2021-03-03
JP2018524979A (ja) 2018-09-06
IL256315B1 (en) 2023-08-01
US20200102374A1 (en) 2020-04-02
KR20180056631A (ko) 2018-05-29
US11248039B2 (en) 2022-02-15
IL256315B2 (en) 2023-12-01
HK1254779A1 (zh) 2019-07-26
AU2016277887B2 (en) 2022-06-09
UA123584C2 (uk) 2021-04-28
CA2989378A1 (fr) 2016-12-22
EP3313432A1 (fr) 2018-05-02
CN108472343B (zh) 2021-12-10

Similar Documents

Publication Publication Date Title
DK3809884T3 (da) Nikotinposeprodukt
FR25C1022I2 (fr) Anticorps anti-pd-1
MA52742A (fr) Anticorps bispécifiques dll3-cd3
EP3817773A4 (fr) Anticorps humanisés dirigés contre c-kit
EP3500301A4 (fr) Anticorps bispécifiques de fab en tandem monovalents asymétriques
HUE051700T2 (hu) Anti-PD-1 antitestek
EP3507307A4 (fr) Anticorps bispécifiques
MA53297A (fr) Anticorps anti-icos
DK3411410T3 (da) Pd-1-antistoffer
MA42626A (fr) Nouveaux anticorps anti-pd-1
EP3334824A4 (fr) Anticorps anti-pd-1
EP3441086A4 (fr) Anticorps monoclonal anti-pd-1
EP3341861A4 (fr) Recommandation de vidéos d'après des titres de vidéos
IL270897A (en) Heterodimerizing ig domains
DK3649152T3 (da) ROR1-antistoffer
EP3732239A4 (fr) Composition de polyéthylène
HUE066651T2 (hu) CD3-t kötõ antitestek
IL270969A (en) Aggrecan binding immunoglobulins
EP3383915A4 (fr) Anticorps anti-pd-1
PT3475303T (pt) Formulações de anticorpos anti-cd19
LT3652491T (lt) Produkto liofilizavimo būdas
EP3735420A4 (fr) Protéines de fusion anticorps-cytosine désaminase à domaine unique
PL3474904T3 (pl) Otrzymywanie przeciwciał monoklonalnych znakowanych 212pb
MA49250A (fr) Nouveaux anticorps anti-cd3
EP3522718A4 (fr) Récepteur d'antigène chimérique à domaine i spécifique d'icam-1